Tumour board

1 · Cancer type (optional)

2 · Biomarkers and alterations

Germline

Germline BRCA1/2 (or PALB2)Adjuvant olaparib in breast cancer (OlympiA); PARP inhibitors in ovarian, prostate, pancreatic cancer; family testing and risk-reducing surgery.
Lynch syndrome (germline MMR)Colonoscopic surveillance, aspirin chemoprevention, immunotherapy for dMMR tumours, interception vaccine trials.

Immune

Stromal TILs ≥ 50%Excellent prognosis in small TNBC; de-escalation trials; more TILs also help immunotherapy.

Not medical advice. This view matches biomarkers to objects documented in OnCo. It does not know your history, stage, fitness, prior treatments, or local availability. Bring it to a real tumour board or oncologist.

Nothing to show yet.

Tick one or more biomarkers on the left, or tap a typical one once you have chosen a cancer type. The matching products, technologies, trials, pairings and ideas appear here, ranked.